Cook Logic
This article was originally published in The Gray Sheet
Executive Summary
Coronary stent clinical trial is anticipated to commence later this year following investigational device exemption clearance from FDA, announced Nov. 17. The 15-site trial will include 400 patients with de novo lesions and 300 patients with acute and threatened vessel closure. The device utilizes a slotted tubular design to provide a low outside diameter profile